Gene · 6495
Papers2,008
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,008
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic associations of variants in 10 glaucoma-related genes with POAG risk and structural phenotypes in Korean subjects. | Medicine (Baltimore) | 2026 | 41894275 | PubTator, text mining | PubMed |
| ESM1 drives cancer angiogenesis and bevacizumab resistance via trioleate synthesis. | Neoplasia | 2026 | 41864037 | PubTator, text mining | PubMed |
| Hearing characteristics of Branchio-oto-renal syndrome in Japan. | Acta Otolaryngol | 2026 | 41842599 | PubTator, text mining | PubMed |
| SENP3 drives colorectal cancer progression by enhancing GDF15 expression. | Int J Colorectal Dis | 2026 | 41824089 | PubTator, text mining | PubMed |
| SIX1 and PAI-1 emerge as therapeutic targets in systemic sclerosis. | Nat Rev Rheumatol | 2026 | 41820592 | PubTator, text mining | PubMed |
| When Estrogen Signaling Refuses to Die: Receptor Rewiring, Compartmentalization, and Endocrine Plasticity in Gynecological Cancers. | Int J Mol Sci | 2026 | 41752059 | PubTator, text mining | PubMed |
| Core Epithelial-to-Mesenchymal Transition Gene Signature Predicts Metastasis and Poor Survival in Synovial Sarcoma. | Cancer Med | 2026 | 41741191 | PubTator, text mining | PubMed |
| The role of epigenetic modifications in hematological cancers. | Front Oncol | 2026 | 41727658 | PubTator, text mining | PubMed |
| Molecular factors associated with lung cancer in people living with HIV. | Braz J Infect Dis | 2026 | 41719623 | PubTator, text mining | PubMed |
| TRIM16: a context-dependent E3 ligase in autophagy, oxidative stress, and immune regulation - from cancer and systemic disease. | Front Oncol | 2026 | 41717414 | PubTator, text mining | PubMed |
| Clinicopathological and functional evaluation of replication protein A in epithelial ovarian cancers: A target validation study. | Transl Oncol | 2026 | 41702233 | PubTator, text mining | PubMed |
| Sine oculis homeobox 1 drives endothelial dysfunction in preclinical pulmonary arterial hypertension. | Sci Transl Med | 2026 | 41637526 | PubTator, text mining | PubMed |
| ISL1: A Novel Neuroendocrine Subtype in Small Cell Lung Cancer Predicts Durable Response to Lurbinectedin. | Mol Cancer Ther | 2026 | 41582485 | PubTator, text mining | PubMed |
| ICG-001 Provides Cardioprotection Against Doxorubicin-Induced Cardiotoxicity and Enhances Cancer Cytotoxicity. | JACC Basic Transl Sci | 2026 | 41579853 | PubTator, text mining | PubMed |
| Retinal determination network reactivation drives chemoresistance and blocks myeloid differentiation in acute myeloid leukemia. | Cell Rep | 2026 | 41575857 | PubTator, text mining | PubMed |
| Integrative Multiomics and Drug Sensitivity Profiling Reveal Potential Biomarkers and Therapeutic Strategies in Pediatric Solid Tumors. | Cancer Res | 2026 | 41417259 | PubTator, text mining | PubMed |
| Multiomic Factor Analysis for Pathologic Complete Response after Pembrolizumab + Trastuzumab + Pertuzumab in HER2-Enriched Early Breast Cancer: WSG-Keyriched-1 Trial. | Clin Cancer Res | 2026 | 41182413 | PubTator, text mining | PubMed |
| Familial Oculoauriculovertebral Spectrum: A Genomic Investigation of Autosomal Dominant Inheritance. | Cleft Palate Craniofac J | 2026 | 39819101 | PubTator, text mining | PubMed |
| The Association of Polygenic Risk Score With Glaucoma and Its Related Traits: Results From Two German Population-Based Studies. | Invest Ophthalmol Vis Sci | 2025 | 41533942 | PubTator, text mining | PubMed |
| Development of a Cellular Senescence-Related Risk Model as a Prognostic Biomarker and Immunotherapy Response in Lung Squamous Cell Carcinoma. | J Coll Physicians Surg Pak | 2025 | 41351089 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6495/papers?page=2